Suppr超能文献

经胸壁小切口入路再次二尖瓣手术安全有效。

Reoperative mitral valve surgery by the port access minithoracotomy approach is safe and effective.

作者信息

Meyer Steven R, Szeto Wilson Y, Augoustides John G T, Morris Rohinton J, Vernick William J, Paschal Deborah, Fox Jeanne, Hargrove W Clark

机构信息

Division of Cardiovascular Surgery, Penn Presbyterian Medical Center, Philadelphia, Pennsylvania 19104, USA.

出版信息

Ann Thorac Surg. 2009 May;87(5):1426-30. doi: 10.1016/j.athoracsur.2009.02.060.

Abstract

BACKGROUND

Reoperative mitral valve (MV) surgery through sternotomy can be technically challenging. Limited exposure and injury to the right ventricle or patent grafts (previous coronary artery bypass graft surgery [CABG]) are potential complications upon sternal reentry. The purpose of this study was to examine the results of port access MV surgery through right minithoracotomy in patients with previous cardiac surgery performed through median sternotomy.

METHODS

From 1998 through July 2007, 651 port access MV procedures were performed. In 107 patients (16.4%), previous cardiac surgery had been performed through midline sternotomy. Mean age was 67.5 +/- 11.2 years, and 60.7% (n = 65) were male. Previous surgery included CABG (n = 45, 42.1%), aortic valve replacement (n = 9, 8.4%), aortic valve replacement/MV repair (n = 2, 1.9%), MV repair (n = 21, 19.6%), MV replacement (n = 5, 4.7%), CABG/MV replacement (n = 1, 0.9%), CABG/MV repair (n = 8, 7.5%), CABG/aortic valve replacement (n = 2, 1.9%), and others (n = 14, 13.1%). New York Heart Association functional classes were I (n = 2, 1.9%), II (n = 28, 26.2%), III (n = 50, 46.7%), and IV (n = 27, 25.2%). The endoaortic balloon was used in 75 patients (70.1%) and the Chitwood clamp in 11 patients (10.2%). In the remaining patients (n = 21, 19.6%), fibrillatory arrest was employed.

RESULTS

Mitral valve repair and MV replacement were performed in 60 patients (56.1%) and 47 patients (43.9%), respectively. The 30-day mortality was 4.7% (n = 5). The mean cardiopulmonary bypass and aortic cross-clamp times were 140.8 +/- 43.7 minutes and 77.0 +/- 49.7 minutes, respectively. Complications included 6 reoperations for bleeding (5.6%), 1 stroke (0.9%), and 2 wound infections (1.9%). Conversion to sternotomy was required in 1 patient (0.9%) because of an acute type A dissection secondary to aortic occlusion with Chitwood clamp. The mean hospital stay was 9.6 days. During follow-up, reoperation for failure of MV repair was performed in 4 patients (3.7%).

CONCLUSIONS

Reoperative port access MV surgery can be performed with minimal morbidity and mortality. This approach may be the preferred technique for patients who require MV procedures after previous cardiac surgery performed through median sternotomy.

摘要

背景

通过胸骨切开术进行再次二尖瓣(MV)手术在技术上可能具有挑战性。胸骨再次切开时,暴露受限以及对右心室或已有的移植物(既往冠状动脉旁路移植术[CABG])造成损伤是潜在的并发症。本研究的目的是探讨在既往通过正中胸骨切开术进行心脏手术的患者中,经右胸小切口进行端口入路MV手术的结果。

方法

1998年至2007年7月,共进行了651例端口入路MV手术。其中107例患者(16.4%)既往曾通过正中胸骨切开术进行过心脏手术。平均年龄为67.5±11.2岁,60.7%(n = 65)为男性。既往手术包括CABG(n = 45,42.1%)、主动脉瓣置换术(n = 9,8.4%)、主动脉瓣置换/MV修复(n = 2,1.9%)、MV修复(n = 21,19.6%)、MV置换(n = 5,4.7%)、CABG/MV置换(n = 1,0.9%)、CABG/MV修复(n = 8,7.5%)、CABG/主动脉瓣置换(n = 2,1.9%)以及其他手术(n = 14,13.1%)。纽约心脏协会心功能分级为I级(n = 2,1.9%)、II级(n = 28,26.2%)、III级(n = 50,46.7%)和IV级(n = 27,25.2%)。75例患者(70.1%)使用了主动脉内球囊,11例患者(10.2%)使用了奇伍德钳。其余患者(n = 21,19.6%)采用了纤维颤动停搏。

结果

分别有60例患者(56.1%)进行了二尖瓣修复和47例患者(43.9%)进行了MV置换。30天死亡率为4.7%(n = 5)。平均体外循环时间和主动脉阻断时间分别为140.8±43.7分钟和77.0±49.7分钟。并发症包括6例因出血而再次手术(5.6%)、1例中风(0.9%)和2例伤口感染(1.9%)。1例患者(0.9%)因奇伍德钳夹闭主动脉继发急性A型夹层而需要转为胸骨切开术。平均住院时间为9.6天。在随访期间,4例患者(3.7%)因MV修复失败而再次手术。

结论

再次端口入路MV手术可以在发病率和死亡率最低的情况下进行。对于既往通过正中胸骨切开术进行心脏手术后需要进行MV手术的患者,这种方法可能是首选技术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验